SB 1452 (2019) -  Prescription Drug Importation Programs

by Gruters
Establishing the Canadian Prescription Drug Importation Program within the Agency for Health Care Administration for a specified purpose; providing eligibility criteria for prescription drugs, for Canadian suppliers, and for importers under the program; requiring the agency to request federal approval of the program; providing requirements for such request; requiring the Department of Business and Professional Regulation to establish the International Prescription Drug Importation Program for a specified purpose, etc.
Effective Date: 07/01/2019
Last Event: 05/03/19 S Died in Health Policy, companion bill(s) passed, see CS/HB 19 (Ch. 2019-99) on Friday, May 3, 2019 11:59 PM

Referred Committees and Committee Actions

Senate Referrals

  • Health Policy
  • Appropriations Subcommittee on Health and Human Services
  • Appropriations

Related Bills

Staff Analysis

(None Available)

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: S Died in Health Policy, companion bill(s) passed, see CS/HB 19 (Ch. 2019-99) Time: 05/03/2019 - 11:59 PM Member: Committee: Health Policy Version: __
Event: S Indefinitely postponed and withdrawn from consideration Time: 05/03/2019 - 11:59 PM Member: Committee: Version: __
Event: S Introduced -SJ 144 Time: 03/05/2019 - 8:20 AM Member: Committee: Version: __
Event: S Referred to Health Policy; Appropriations Subcommittee on Health and Human Services; Appropriations -SJ 144 Time: 03/04/2019 - 6:25 PM Member: Committee: Health Policy Version: __
Event: S Filed Time: 02/27/2019 - 2:22 PM Member: Committee: Version: __